Soy protein isolate modified metabolic phenotype and hepatic Wnt signaling in obese Zucker rats.
We have previously shown that soy protein isolate (SPI) with intact phytoestrogen content prevented obesity-related dysfunction. Recent data have suggested that soy ingredients may act as regulators of adipogenic programming in adipose tissue (AT) and liver. Thus, the current study was undertaken to determine whether the beneficial effects of SPI are linked to changes in adipogenic regulators, such as the Wnt signaling cascade. For this, lean (LZR) and obese Zucker (OZR) rats were provided isocaloric and isonitrogenous diets containing SPI, sodium caseinate, or dairy whey protein for 17 weeks. At termination, SPI increased body weight and total adiposity in rodents, which corresponded with an increase in both adipocyte size and number. Furthermore, markers of inflammation, hypercholesterolemia, and hepatic steatosis were all reduced in OZR rats provided SPI. Transcript abundance of several canonical and noncanonical Wnt signaling intermediates in liver, but not AT, was distinctly modified by SPI. Collectively, these data confirm the protective SPI attenuated obesity-related metabolic dysfunction conceivably through regulation of adipogenic programming, as evident by changes in AT morphology and hepatic Wnt signaling. Collectively, this study confirmed the potential utilization of soy protein and its bioactive ingredients for prevention and treatment of obesity-related comorbidities.
Animal Science, Food & Nutrition, Southern Illinois University, Carbondale, IL 62901, USA.
J
J
Cain
W J
WJ
Banz
D
D
Butteiger
J E
JE
Davis
D050156:Adipogenesis; D052436:Adipose Tissue, White / Q000378:metabolism / Q000473:pathology; D050154:Adiposity; D000818:Animals; D002097:C-Reactive Protein / Q000032:analysis; D002452:Cell Count; D048429:Cell Size; D004822:Epididymis; D005234:Fatty Liver / Q000209:etiology / Q000517:prevention & control; D005786:Gene Expression Regulation; D006937:Hypercholesterolemia / Q000209:etiology / Q000517:prevention & control; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008297:Male; D009765:Obesity / Q000178:diet therapy* / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D009929:Organ Size; D011897:Random Allocation; D051381:Rats; D011924:Rats, Zucker; D000683:Serum Amyloid P-Component / Q000032:analysis; D015398:Signal Transduction; D030262:Soybean Proteins / Q000627:therapeutic use*; D051153:Wnt Proteins / Q000235:genetics / Q000378:metabolism*
D000683:Serum Amyloid P-Component; D030262:Soybean Proteins; D051153:Wnt Proteins; D002097:C-Reactive Protein